The University of Nottingham, UK conducted a study suggesting statins are ineffective at lowering cholesterol to target levels in more than half of patients. Published in the journal Heart, the UK researchers found 51.2% of patients prescribed statins saw minimal benefit to their cholesterol levels within two years. Consequently, this patient class faced significant risk of developing future cardiovascular disease. On the other hand, the remaining 48.8% experienced materially successful lowered cholesterol by at least 40% but also better outcomes combatting classical cardiovascular disease conditions such as heart attack, stroke and narrowing arteries.
The study reveals the significant lack of personalization or precision when it comes today’s statin patient market. Statins are widely utilized drug for “bad cholesterol” or “low density lipoprotein cholesterol” (LDL-C)—a known contributor to the risk for the hardening and narrowing of the arteries.
The study, led by Dr. Stephen Weng, analyzed 165,400 GP patients from the UK Clinical Practice Research Datalink system who had previously been unaffected by cardiovascular disease before being prescribed statins reports the Unive...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).